“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer

€3.03

SKU: product-article-11279 Category: General

Description
Reviews (0)

Description

Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer

Reviews

There are no reviews yet.

Be the first to review “Article: Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer”

You must be logged in to post a review.

Top

Article: Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer

Description

Reviews

Related products

Article: Highlights in genitourinary cancers

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in melanoma

Article: Highlights in squamous cell carcinoma of the head and neck